State-owned pharmaceutical group Saidal inaugurated Algeria’s first bioequivalence center in Algiers on Sunday, dubbed the “Equival Biocenter”, which will be tasked with carrying out studies to prove the efficacy and safety of generic drugs. Read more…
Towards pharmaceutical self-sufficiency
Algeria has taken a crucial step in its strategy of pharmaceutical self-sufficiency, with the official inauguration of the second private bioequivalence center launched by Clinica Group. Read more…
October 30, 2024
